Masimo

Masimo is a medical technology company that develops, manufactures, and markets non-invasive monitoring technologies worldwide. Founded in 1989 and headquartered in California, USA, the company’s mission is to improve patient outcomes and reduce the cost of care. In 1995, Masimo introduced MasimoSET®, a pulse oximetry technology capable of taking measurements during motion and low perfusion. This method has been proven in numerous studies to significantly reduce false alarms while accurately detecting true events. MasimoSET® has also been shown to help clinicians reduce retinopathy of prematurity (ROP) in neonates and improve CCHD screening for newborns. MasimoSET® has helped clinicians monitor over 200 million patients in healthcare settings globally. Among the top 10 hospitals listed in the U.S. News & World Report Best Hospitals Honor Roll for 2018-2019, nine use MasimoSET® as their primary pulse oximeter.